Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068677 · ClinicalTrials.gov registry record · NA
Evaluation of Injection Techniques in Celiac Plexus Neurolysis
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02068677 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 51 participants.
The verdict
NCT02068677, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
1\. To evaluate the efficacy of EUS-CPN in subjects who experience a sympathetic response during injection when compared with subjects who do not experience sympathetic response during injection. EUS-CPN when performed in subjects who experience a sympathetic response during injection will have better pain relief when compared to subjects who do not experience a sympathetic response during injection.
Interventions
- OTHER Sympathetic response
- OTHER no sympathetic response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068677
The ClinicalTrials.gov registry entry for NCT02068677 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sympathetic response is the first listed.
NCT02068677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068677 about?
NCT02068677 is a clinical study titled "Evaluation of Injection Techniques in Celiac Plexus Neurolysis". 1\. To evaluate the efficacy of EUS-CPN in subjects who experience a sympathetic response during injection when compared with subjects who do not experience sympathetic response during injection. EUS-CPN when performed in subjects who experience a sympathetic response during injection will have bet...
What is the current status of trial NCT02068677?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-08. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02068677?
The interventions under investigation include: Sympathetic response (OTHER), no sympathetic response (OTHER).
Who is sponsoring clinical trial NCT02068677?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.